uniQure N.V. (NASDAQ: QURE)’s stock price has soared by 3.39 in relation to previous closing price of 7.66. Nevertheless, the company has seen a loss of -0.13% in its stock price over the last five trading days. The Motley Fool reported 2023-09-05 that The Food and Drug Administration has cleared uniQure’s application for an epilepsy therapy. The company grew revenue in the second quarter by 380%, year over year.
Is It Worth Investing in uniQure N.V. (NASDAQ: QURE) Right Now?
while the 36-month beta value is 1.00.Analysts have differing opinions on the stock, with 13 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
The average price point forecasted by analysts for uniQure N.V. (QURE) is $36.31, which is $28.79 above the current market price. The public float for QURE is 44.69M, and currently, short sellers hold a 5.30% ratio of that floaft. The average trading volume of QURE on September 18, 2023 was 1.10M shares.
QURE’s Market Performance
QURE stock saw a decrease of -0.13% in the past week, with a monthly decline of -6.93% and a quarterly a decrease of -58.34%. The volatility ratio for the week is 4.48%, and the volatility levels for the last 30 days are 4.99% for uniQure N.V. (QURE). The simple moving average for the past 20 days is -5.09% for QURE’s stock, with a -55.21% simple moving average for the past 200 days.
Analysts’ Opinion of QURE
Many brokerage firms have already submitted their reports for QURE stocks, with UBS repeating the rating for QURE by listing it as a “Buy.” The predicted price for QURE in the upcoming period, according to UBS is $40 based on the research report published on March 17, 2022 of the previous year 2022.
QURE Trading at -14.81% from the 50-Day Moving Average
After a stumble in the market that brought QURE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.97% of loss for the given period.
Volatility was left at 4.99%, however, over the last 30 days, the volatility rate increased by 4.48%, as shares sank -4.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.96% lower at present.
During the last 5 trading sessions, QURE fell by -0.13%, which changed the moving average for the period of 200-days by -71.01% in comparison to the 20-day moving average, which settled at $8.32. In addition, uniQure N.V. saw -65.06% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at QURE starting from CALOZ PIERRE, who sale 15,117 shares at the price of $11.36 back on Jul 10. After this action, CALOZ PIERRE now owns 95,098 shares of uniQure N.V., valued at $171,729 using the latest closing price.
Gut Robert, the Director of uniQure N.V., sale 3,228 shares at $18.88 during a trade that took place back on Jun 16, which means that Gut Robert is holding 47,669 shares at $60,945 based on the most recent closing price.
Stock Fundamentals for QURE
Current profitability levels for the company are sitting at:
- -133.76 for the present operating margin
- +88.84 for the gross margin
The net margin for uniQure N.V. stands at -119.07. The total capital return value is set at -21.09, while invested capital returns managed to touch -18.98. Equity return is now at value -44.90, with -25.60 for asset returns.
Based on uniQure N.V. (QURE), the company’s capital structure generated 30.02 points at debt to equity in total, while total debt to capital is 23.09. Total debt to assets is 20.27, with long-term debt to equity ratio resting at 28.26. Finally, the long-term debt to capital ratio is 21.73.
When we switch over and look at the enterprise to sales, we see a ratio of 1.50, with the company’s debt to enterprise value settled at 0.17. The receivables turnover for the company is 1.32 and the total asset turnover is 0.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.28.
Conclusion
In a nutshell, uniQure N.V. (QURE) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
